{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:19:28Z","timestamp":1754111968359},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1007\/s11938-004-0018-0","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T19:14:32Z","timestamp":1180898072000},"page":"317-325","source":"Crossref","is-referenced-by-count":34,"title":["Chronic intestinal pseudoobstruction"],"prefix":"10.1007","volume":"7","author":[{"given":"Greg","family":"Lyford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Foxx-Orenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0016-5085(00)70409-4","volume":"118","author":"CL He","year":"2000","unstructured":"He CL, Burgart L, Wang L, et al.: Decreased interstitial cell of cajal volume in patients with slow-transit constipation. Gastroenterology 2000, 118: 14\u201321.","journal-title":"Gastroenterology"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1572-0241.2002.05851.x","volume":"97","author":"DS Pardi","year":"2002","unstructured":"Pardi DS, Miller SM, Miller DL, et al.: Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol 2002, 97: 1828\u20131833.","journal-title":"Am J Gastroenterol"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/BF01536716","volume":"34","author":"N Sodhi","year":"1989","unstructured":"Sodhi N, Camilleri M, Camoriano JK, et al.: Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989, 34: 1937\u20131942.","journal-title":"Dig Dis Sci"},{"key":"18_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","volume":"341","author":"RB Darnell","year":"1993","unstructured":"Darnell RB, DeAngelis LM: Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993, 341: 21\u201322.","journal-title":"Lancet"},{"key":"18_CR5","first-page":"68","volume":"5","author":"J Kuemmerle","year":"1994","unstructured":"Kuemmerle J, Foxx-Orenstein A: Narcotic bowel syndrome. Reg Peptide Letter 1994, 5: 68\u201369.","journal-title":"Reg Peptide Letter"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0025-7125(16)31475-4","volume":"65","author":"MD Schuffler","year":"1981","unstructured":"Schuffler MD: Chronic intestinal pseudo-obstruction syndromes. Med Clin North Am 1981, 65: 1331\u20131358.","journal-title":"Med Clin North Am"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.1978.03290190053030","volume":"240","author":"DL Faulk","year":"1978","unstructured":"Faulk DL, Anuras S, Freeman JB: Idiopathic chronic intestinal pseudo-obstruction: use of central venous nutrition. JAMA 1978, 240: 2075\u20132076.","journal-title":"JAMA"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1023\/A:1020199614102","volume":"47","author":"H Mousa","year":"2002","unstructured":"Mousa H, Hyman PE, Cocjin J, et al.: Long-term outcome of congenital intestinal pseudoobstruction. Dig Dis Sci 2002, 47: 2298\u20132305.","journal-title":"Dig Dis Sci"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004836-199204000-00013","volume":"14","author":"MJ Vassallo","year":"1992","unstructured":"Vassallo MJ, Camilleri M, Sullivan SN, Thomforde GM: Effects of erythromycin on gut transit in pseudoobstruction due to hereditary coproporphyria [Comment]. J Clin Gastroenterol 1992, 14: 255\u2013259.","journal-title":"J Clin Gastroenterol"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/BF02358615","volume":"31","author":"T Minami","year":"1996","unstructured":"Minami T, Nishibayashi H, Shinomura Y, Matsuzawa Y: Effects of erythromycin in chronic idiopathic intestinal pseudo-obstruction. J Gastroenterol 1996, 31: 855\u2013859.","journal-title":"J Gastroenterol"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01072287","volume":"22","author":"AB Lipton","year":"1977","unstructured":"Lipton AB, Knauer CM: Pseudo-obstruction of the bowel: therapeutic trial of metoclopramide. Am J Dig Dis 1977, 22: 263\u2013265.","journal-title":"Am J Dig Dis"},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","volume":"325","author":"HC Soudah","year":"1991","unstructured":"Soudah HC, Hasler WL, Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991, 325: 1461\u20131467.","journal-title":"N Engl J Med"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0022-3476(88)80211-7","volume":"112","author":"PE Hyman","year":"1988","unstructured":"Hyman PE, McDiarmid SV, Napolitano J, et al.: Antroduodenal motility in children with chronic intestinal pseudo-obstruction. J Pediatr 1988, 112: 899\u2013905.","journal-title":"J Pediatr"},{"key":"18_CR14","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/0016-5085(91)90393-Y","volume":"101","author":"C Lorenzo Di","year":"1991","unstructured":"Di Lorenzo C, Reddy SN, Villanueva-Meyer J, et al.: Cisapride in children with chronic intestinal pseudoobstruction: an acute, double-blind, crossover, placebocontrolled trial. Gastroenterology 1991, 101: 1564\u20131570.","journal-title":"Gastroenterology"},{"key":"18_CR15","first-page":"832","volume":"88","author":"PE Hyman","year":"1993","unstructured":"Hyman PE, Di Lorenzo C, McAdams L, et al.: Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol 1993, 88: 832\u2013836. Report of the clinical factors in chronic intestinal pseudoobstruction that predict responsiveness to pharmacologic therapy.","journal-title":"Am J Gastroenterol"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.0953-0673.1996.00403.x","volume":"10","author":"M Camilleri","year":"1996","unstructured":"Camilleri M, Balm RK, Zinsmeister AR: Symptomatic improvement with 1-year cisapride treatment in neuropathic chronic intestinal dysmotility. Aliment Pharmacol Ther 1996, 10: 403\u2013409.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2001.01094.x","volume":"15","author":"S Muller-Lissner","year":"2001","unstructured":"Muller-Lissner S, Fumagalli I, Bardhan KD, et al.: Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating, and constipation. Aliment Pharmacol Ther 2001, 15: 1655\u20131666.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1046\/j.1365-2036.2002.01372.x","volume":"16","author":"J Novick","year":"2002","unstructured":"Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002, 16: 1877\u20131688.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","volume":"15","author":"L Degen","year":"2001","unstructured":"Degen L, Matzinger D, Merz M, et al.: Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001, 15: 1745\u20131751.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","volume":"118","author":"C Prather","year":"2000","unstructured":"Prather C, Camilleri M, Zinsmeister AR, et al.: Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000, 118: 463\u2013468.","journal-title":"Gastroenterology"},{"key":"18_CR21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/gut.29.11.1613","volume":"29","author":"MM Mughal","year":"1988","unstructured":"Mughal MM, Irving MH: Treatment of end-stage chronic intestinal pseudo-obstruction by subtotal enterectomy and home parenteral nutrition. Gut 1988, 29: 1613\u20131617.","journal-title":"Gut"},{"key":"18_CR22","first-page":"2147","volume":"90","author":"MM Murr","year":"1995","unstructured":"Murr MM, Sarr MG, Camilleri M: The surgeon\u2019s role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995, 90: 2147\u20132151. Excellent discussion of experience in surgical management of chronic intestinal pseudo-obstruction.","journal-title":"Am J Gastroenterol"},{"key":"18_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00383-003-0973-x","volume":"19","author":"A Nayci","year":"2003","unstructured":"Nayci A, Nayci A, Avlan D, Polat A, Aksoyek S: Treatment of intestinal pseudo-obstruction by segmental resection. Pediatr Surg Int 2003, 19: 44\u201346.","journal-title":"Pediatr Surg Int"},{"key":"18_CR24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archsurg.1985.01390290090015","volume":"120","author":"HA Pitt","year":"1985","unstructured":"Pitt HA, Mann LL, Berquist WE, et al.: Chronic intestinal pseudo-obstruction: management with total parenteral nutrition and a venting enterostomy. Arch Surg 1985, 120: 614\u2013618.","journal-title":"Arch Surg"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(96)91619-0","volume":"347","author":"D Grant","year":"1996","unstructured":"Grant D: Current results of intestinal transplantation: the International Intestinal Transplant Registry. Lancet 1996, 347: 1801\u20131803. Review of the results of intestinal transplantation for chronic intestinal pseudo-obstruction and other disorders.","journal-title":"Lancet"},{"key":"18_CR26","first-page":"G979","volume":"275","author":"AE Foxx-Orenstein","year":"1998","unstructured":"Foxx-Orenstein AE, Jin JG, Grider JR: 5-HT4 receptor agonists and d-opioid receptor antagonists act synergistically to stimulate colonic propulsion. Am J Physiol 1998, 275: G979-G983. First study to identify that the combination of a 5-HT4 agonist and an opioid antagonist result in a marked increase in colonic propulsion in in vitro studies. It also discusses clinical implications.","journal-title":"Am J Physiol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-004-0018-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-004-0018-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-004-0018-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:59Z","timestamp":1559437019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-004-0018-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s11938-004-0018-0","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}